FDA APPROVES ZARS PHARMA'S TOPICAL LOCAL ANESTHETIC

A A

ZARS Pharma has announced the FDA has approved a topical local anesthetic peel developed under the name of S-Caine(TM) Peel (Lidocaine and Tetracaine) 7%/7% Cream.

The product will be used to locally anesthetize intact skin before various superficial dermatological procedures such as dermal filler procedures, pulsed dye laser therapy, facial laser resurfacing and laser-assisted tattoo removal. The product is indicated for use in adults.

The Lidocaine and Tetracaine 7%/7% Cream forms a pliable peel on the skin when exposed to air. The product is applied for 20 to 30 minutes prior to procedures such as dermal filler injections or facial laser ablation, and for 60 minutes for procedures such as laser-assisted tattoo removal.